Renalytix Plc
RNLXY
$1.24
-$0.13-9.19%
OTC PK
| 12/31/2025 | 09/30/2025 | 12/31/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -- | -- | 44.04% | 5.47% | 6.35% |
| Total Depreciation and Amortization | -- | -- | -89.82% | -47.04% | 161.69% |
| Total Amortization of Deferred Charges | -- | -- | -50.00% | 100.00% | 789.66% |
| Total Other Non-Cash Items | -- | -- | 38.81% | 181.93% | -10.00% |
| Change in Net Operating Assets | -- | -- | -486.43% | 207.41% | -67.15% |
| Cash from Operations | -- | -- | 36.42% | 21.96% | 1.86% |
| Capital Expenditure | -- | -- | -- | -104.84% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 196.72% | 196.97% |
| Cash from Investing | -- | -- | -106.25% | 5,500.00% | 175.29% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -9.65% | 51.62% | -100.13% |
| Issuance of Common Stock | -- | -- | 56.00% | -81.88% | 127.93% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -71.79% | 39.59% | 37.75% |
| Cash from Financing | -- | -- | 64.09% | -94.35% | -31.42% |
| Foreign Exchange rate Adjustments | -- | -- | -117.35% | 111.63% | 151.91% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -- | 119.57% | -4,352.70% | -13.16% |